Berger P A, Ginsburg R A, Barchas J D, Murphy D L, Wyatt R J
Am J Psychiatry. 1978 Jan;135(1):95-9. doi: 10.1176/ajp.135.1.95.
The authors investigated platelet monoamine (MAO) activity in 40 chronic schizophrenic patients, 55 normal control subjects, and 16 hospitalized control subjects. The mean platelet MAO activity for the chronic schizophrenic patients was significantly lower than the mean in either control group. There were no significant differences between the mean platelet MAO activities in 21 chronic paranoid schizophrenic patients compared with 18 chronic undifferentiated schizophrenic patients.
作者对40名慢性精神分裂症患者、55名正常对照者和16名住院对照者的血小板单胺(MAO)活性进行了研究。慢性精神分裂症患者的平均血小板MAO活性显著低于两个对照组中的任何一组。21名慢性偏执型精神分裂症患者与18名慢性未分化型精神分裂症患者的平均血小板MAO活性之间无显著差异。